1. Lessons from the withdrawal of rofecoxib, France has policy for overall assessment of public health impact of new drugs;Abenhaim;British Medical Journal,2004
2. The state, business, and industrial change in Canada;Atkinson,1989
3. Powerful medicines: The benefits, risks and costs of prescription drugs;Avorn,2005
4. Loading the dice: A five country study of vinyl chloride regulation;Badaracco,1985
5. Deliverable 2–8: Final report on the PMR/PMC backlog review;Booz,2009